new glp 1 drug Diabetes Patients Also Struggle to Access GLP-1 Agonists Comparing Ozempic, Wegovy and Other

GLP-1 Side Effects and Safety GLP-1 medications are considered safe when prescribed and monitored by a medical professional

Three semaglutide medications are currently approved by the FDA: Wegovy is approved for weight loss treatment, and can be prescribed to adults and children 12 and older with obesity, as well as some adults with overweight who also have weight-related health problems, such as high blood pressure

Simultaneously, it decreases NPY and AgRP expression, the peptides that drive hunger and food-seeking behavior

A large-scale observational study published in 2023 analyzed electronic health records of over 80,000 patients with obesity and found that those prescribed semaglutide had a 50-56% lower risk of alcohol use disorder compared to those on other obesity medications

Psychiatric safety of semaglutide for weight management in people without known major psychopathology: post hoc analysis of the STEP 1, 2, 3, and 5 trials

Diabetes contributes to structural and electrical changes in the heart, increasing susceptibility to arrhythmias